Promotion of Nonspecific Cytotoxic T Lymphocyte Activity by Bo-yang-hwan-oh-tang

보양환오탕에 의한 비특이적 세포독성 T 세포 활성 증강

  • Ha, Jong-Cheon (Department of Microbiology, School of Natural Science, Jeonju University) ;
  • Kim, Young-Hyun (Department of Microbiology, School of Natural Science, Jeonju University) ;
  • Woo, Won-Hong (Department of Pathology, College of Oriental Medicine, Wonkwang University) ;
  • Nam, Sang-Yun (Department of Microbiology, School of Natural Science, Jeonju University)
  • 하종천 (전주대학교 자연과학부) ;
  • 김영현 (전주대학교 자연과학부) ;
  • 우원홍 (원광대학교 한의과대학 병리학교실) ;
  • 남상윤 (전주대학교 자연과학부)
  • Published : 2001.09.30

Abstract

To explore the possible cancer therapeutic application of "Bo-yang-hwan-oh-tang" (BH), a herbal medicinal recipe used for improvement of blood stasis, we have examined its direct cytotoxicity against tumor cell, and induction of cytotoxic activity of lymphocytes. Water extract of BH alone did not exhibit direct cytotoxicity to Yac-1 target cells even with high concentrations (10 mg/ml). By exposure for 3 days, BH did not induce any nonspecific cytotoxic activity of mouse spleen cells, either, when assessed in a 4 hr $^{51}Cr-release$ assay. However, when BH was added during CD3 stimulation of non-adherent spleen cells, non-specific CTL activity was markedly promoted in a dose dependent manner. In contrast, BH did not alter activated NK cell activity following IL-2 stimulation. These data suggest that BH does not induce but upregulates non-specific CTL effecter function and that activated NK cell does not respond to BH. For elucidation of the mechanism underlying this function of BH, time kinetic study for IL-2 production using ELISA was undertaken. IL-2 production following CD3 stimulation was significantly augmented and higher level of IL-2 is sustained over 3 days in the culture medium by BH treatment. Moreover, addition of exogenous IL-2 during CD3 stimulation resulted in a similar level of cytotoxicity between control and BH-treated culture. These data indicate that the BH-mediated upregulation of non-specific CTL activity is contributed by augmentation of IL-2 production. Our data imply the possible application of BH for combination therapy of cancer with non-specific activator.

Keywords